Cosmos Health (COSM) EBITDA Margin (2014 - 2026)
Cosmos Health (COSM) recorded quarterly EBITDA Margin of 17.29% in Q1 2026, down 172.06% on a QoQ basis from 24.0% in Q4 2025, and down 1885.0% year-over-year from 0.97% in Q1 2025.
Cosmos Health (COSM) EBITDA Margin (2014 - 2026) Analysis & Trends
Cosmos Health has disclosed EBITDA Margin across 12 years of filings, most recently posting 17.29% for Q1 2026.
- Quarterly EBITDA Margin fell 1885.0% year-over-year to 17.29% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 337.97% (down 29799.0% YoY) and the FY2025 annual result came in at 981.09%, down 93682.0% from the prior year.
- EBITDA Margin slipped to 17.29% in Q1 2026, from 24.0% in the prior quarter.
- Over five years, EBITDA Margin peaked at 24.0% in Q4 2025 and troughed at 303.88% in Q4 2022.
- A 5-year average of 52.69% and a median of 25.15% in 2022 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2022 — EBITDA Margin plunged 24563 bps — and 2023, when it jumped 17892 bps.
- Tracing COSM's EBITDA Margin over 5 years: stood at 303.88% in 2022, then soared by 59 bps to 124.97% in 2023, then soared by 37 bps to 78.95% in 2024, then jumped by 130 bps to 24.0% in 2025, then sank by 172 bps to 17.29% in 2026.
- Business Quant data shows COSM's EBITDA Margin at 17.29% in Q1 2026, 24.0% in Q4 2025, and 29.79% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 2.23% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 1.63% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 0.84% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 5.40% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 7.33% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -41.35% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -0.59% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -17.29% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.29% |
| Dec 31, 2025 | 24.00% |
| Sep 30, 2025 | -29.79% |
| Jun 30, 2025 | -8.58% |
| Mar 31, 2025 | 1.55% |
| Dec 31, 2024 | -78.95% |
| Sep 30, 2024 | -61.47% |
| Jun 30, 2024 | -20.95% |
| Mar 31, 2024 | -16.91% |
| Dec 31, 2023 | -124.97% |
| Sep 30, 2023 | -33.18% |
| Jun 30, 2023 | -7.27% |
| Mar 31, 2023 | -1.00% |
| Dec 31, 2022 | -303.88% |
| Sep 30, 2022 | -25.15% |
| Jun 30, 2022 | -146.06% |
| Mar 31, 2022 | -45.83% |
| Dec 31, 2021 | -58.25% |
| Sep 30, 2021 | -15.82% |
| Jun 30, 2021 | -8.74% |